Short-term Glucocorticoid Combined with MMF for IgG4-RD
ConditionIgG4-related Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorWen Zhang
About this trial
Comparison of short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease
Eligibility criteria
Qualifiers
18-80 years old;
All patients must meet the comprehensive diagnostic criteria of IgG4-RD revised in Japan in 2020 or the classification criteria of IgG4-RD formulated by ACR/EULAR in 2019;
Active IgG4-RD (at least one organ has an IgG4-RD reaction score >=2 at the time of enrollment.)；
No previous medication or recurrence after withdrawal.
Disqualifiers
Combined with other autoimmune diseases as the main diagnosis.
Pregnant or lactating women
Patients with malignant tumor
Active bacterial, fungal, viral or mycobacterial infections.
Trial design
Treatments tested in this trial
- prednison
- Mycophenolate mofetil
Treatment groups
63 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wen Zhang
Lead sponsor
Peking Union Medical College Hospital
Sponsor institution
Source ClinicalTrials.gov